Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > True Story
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(192)
•••
Comment by craighenryon Jan 24, 2023 12:03pm
109 Views
Post# 35242495

RE:RE:RE:RE:RE:RE:True Story

RE:RE:RE:RE:RE:RE:True Story
Boomskid wrote: I just read your post, Craig. It was hilarious.

Now you're blaming others for what you posted about Mark, Catherine and me.

Somebody DM'd you! 

Can't make this up.

And now, because they don't support your story, you're going to attack them about airplane seats. My guess is that the two of them, first class, didn't cost as much as flights from Australia to deliver more bad news to shareholders, and smile over it.

jd



Make what up JBroke?

The fact that someone in the know DMd me about their lavash spending?  Absolutely!!  How in the hell else would I know?

Prove me wrong JBroke!  Prove me wrong they didn't write off THOUSANDS for expenses!



And I highly doubt a 3 day old alias is really who they "say they are.



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities